FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153644370> ?p ?o ?g. }

• W2153644370 endingPage "549" @default.
• W2153644370 startingPage "545" @default.
• W2153644370 abstract "Oral administration of autoantigens can slow the progression of beta-cell destruction in non-obese diabetic mice. We investigated whether oral administration of recombinant human insulin could protect residual beta-cell function in recent-onset type 1 diabetes.We enrolled 131 autoantibody-positive diabetic patients aged 7-40 years within 2 weeks of diagnosis (no ketoacidosis at diagnosis, weight loss <10%, polyuria for <6 weeks). They were randomly assigned 2.5 mg or 7.5 mg oral insulin daily or placebo for 1 year, in addition to subcutaneous insulin therapy. Serum C-peptide concentrations were measured in the fasting state and after stimulation, to assess beta-cell function. Autoantibodies to beta-cell antigens were assayed. Analyses were by intention to treat.Baseline C-peptide and haemoglobin A1c concentrations were similar in the three groups. During follow-up, there were no differences between the groups assigned 2.5 mg or 7.5 mg oral insulin or placebo in subcutaneous insulin requirements, haemoglobin A1c concentrations, or measurements of fasting (mean at 12 months 0.18 [SD 0.17], 0.17 [0.17], and 0.17 [0.12] nmol/L) or stimulated C-peptide concentrations (glucagon-stimulated 0.39 [0.38], 0.37 [0.39], and 0.33 [0.24] nmol/L; meal-stimulated 0.72 [0.60], 0.49 [0.49], and 0.57 [0.51 nmol/L]. Neither age nor C-peptide concentration at entry influenced treatment effects. No differences were seen in the time-course or titres of antibodies to insulin, glutamic acid decarboxylase, or islet antigen 2.At the doses used in this trial, oral administration of insulin initiated at clinical onset of type 1 diabetes did not prevent the deterioration of beta-cell function." @default.
• W2153644370 created "2016-06-24" @default.
• W2153644370 creator A5002054019 @default.
• W2153644370 creator A5003561098 @default.
• W2153644370 creator A5006532808 @default.
• W2153644370 creator A5010474043 @default.
• W2153644370 creator A5012841449 @default.
• W2153644370 creator A5025169113 @default.
• W2153644370 creator A5026080354 @default.
• W2153644370 creator A5026786945 @default.
• W2153644370 creator A5031452020 @default.
• W2153644370 creator A5041483932 @default.
• W2153644370 creator A5047311157 @default.
• W2153644370 creator A5058753169 @default.
• W2153644370 creator A5065867717 @default.
• W2153644370 creator A5070226523 @default.
• W2153644370 creator A5081702924 @default.
• W2153644370 date "2000-08-01" @default.
• W2153644370 modified "2023-10-16" @default.
• W2153644370 title "Oral insulin administration and residual (β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial" @default.
• W2153644370 cites W1606951746 @default.
• W2153644370 cites W1614840242 @default.
• W2153644370 cites W1964262147 @default.
• W2153644370 cites W1972735675 @default.
• W2153644370 cites W1992139746 @default.
• W2153644370 cites W2001921755 @default.
• W2153644370 cites W2005786957 @default.
• W2153644370 cites W2006260488 @default.
• W2153644370 cites W2008171808 @default.
• W2153644370 cites W2013846645 @default.
• W2153644370 cites W2017894510 @default.
• W2153644370 cites W2019398337 @default.
• W2153644370 cites W2029196267 @default.
• W2153644370 cites W2036202576 @default.
• W2153644370 cites W2049710430 @default.
• W2153644370 cites W2079788829 @default.
• W2153644370 cites W2084080341 @default.
• W2153644370 cites W2090098475 @default.
• W2153644370 cites W2102348355 @default.
• W2153644370 cites W2134219151 @default.
• W2153644370 cites W2136697225 @default.
• W2153644370 cites W2150631622 @default.
• W2153644370 cites W2154652130 @default.
• W2153644370 cites W2160738923 @default.
• W2153644370 cites W2315874408 @default.
• W2153644370 cites W2341744959 @default.
• W2153644370 doi "https://doi.org/10.1016/s0140-6736(00)02579-4" @default.
• W2153644370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10950231" @default.
• W2153644370 hasPublicationYear "2000" @default.
• W2153644370 type Work @default.
• W2153644370 sameAs 2153644370 @default.
• W2153644370 citedByCount "221" @default.
• W2153644370 countsByYear W21536443702012 @default.
• W2153644370 countsByYear W21536443702013 @default.
• W2153644370 countsByYear W21536443702014 @default.
• W2153644370 countsByYear W21536443702015 @default.
• W2153644370 countsByYear W21536443702016 @default.
• W2153644370 countsByYear W21536443702017 @default.
• W2153644370 countsByYear W21536443702018 @default.
• W2153644370 countsByYear W21536443702019 @default.
• W2153644370 countsByYear W21536443702020 @default.
• W2153644370 countsByYear W21536443702021 @default.
• W2153644370 countsByYear W21536443702022 @default.
• W2153644370 crossrefType "journal-article" @default.
• W2153644370 hasAuthorship W2153644370A5002054019 @default.
• W2153644370 hasAuthorship W2153644370A5003561098 @default.
• W2153644370 hasAuthorship W2153644370A5006532808 @default.
• W2153644370 hasAuthorship W2153644370A5010474043 @default.
• W2153644370 hasAuthorship W2153644370A5012841449 @default.
• W2153644370 hasAuthorship W2153644370A5025169113 @default.
• W2153644370 hasAuthorship W2153644370A5026080354 @default.
• W2153644370 hasAuthorship W2153644370A5026786945 @default.
• W2153644370 hasAuthorship W2153644370A5031452020 @default.
• W2153644370 hasAuthorship W2153644370A5041483932 @default.
• W2153644370 hasAuthorship W2153644370A5047311157 @default.
• W2153644370 hasAuthorship W2153644370A5058753169 @default.
• W2153644370 hasAuthorship W2153644370A5065867717 @default.
• W2153644370 hasAuthorship W2153644370A5070226523 @default.
• W2153644370 hasAuthorship W2153644370A5081702924 @default.
• W2153644370 hasConcept C126322002 @default.
• W2153644370 hasConcept C134018914 @default.
• W2153644370 hasConcept C142724271 @default.
• W2153644370 hasConcept C159654299 @default.
• W2153644370 hasConcept C163764329 @default.
• W2153644370 hasConcept C165220095 @default.
• W2153644370 hasConcept C203014093 @default.
• W2153644370 hasConcept C204787440 @default.
• W2153644370 hasConcept C27081682 @default.
• W2153644370 hasConcept C2775849729 @default.
• W2153644370 hasConcept C2776828364 @default.
• W2153644370 hasConcept C2777056448 @default.
• W2153644370 hasConcept C2777180221 @default.
• W2153644370 hasConcept C2778875212 @default.
• W2153644370 hasConcept C2779306644 @default.
• W2153644370 hasConcept C2780180277 @default.
• W2153644370 hasConcept C2781232474 @default.
• W2153644370 hasConcept C2781283889 @default.
• W2153644370 hasConcept C555293320 @default.

• next